X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5549) 5549
Publication (1104) 1104
Book Chapter (109) 109
Book Review (60) 60
Conference Proceeding (23) 23
Dissertation (12) 12
Newsletter (11) 11
Reference (8) 8
Book / eBook (5) 5
Newspaper Article (4) 4
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2857) 2857
animals (2528) 2528
humans (2212) 2212
pharmacology & pharmacy (1435) 1435
allosteric regulation (1391) 1391
neurosciences (1029) 1029
rats (991) 991
ligands (899) 899
biochemistry & molecular biology (830) 830
allosteric properties (803) 803
chemistry, medicinal (761) 761
positive allosteric modulator (720) 720
male (714) 714
article (678) 678
allosteric regulation - drug effects (660) 660
mice (644) 644
binding sites (632) 632
allosteric modulators (606) 606
structure-activity relationship (603) 603
activation (568) 568
proteins (544) 544
pharmacology (519) 519
allosteric modulator (500) 500
models, molecular (483) 483
protein binding (483) 483
schizophrenia (478) 478
dose-response relationship, drug (474) 474
glutamate (470) 470
drug discovery (468) 468
receptors (450) 450
allosteric site (433) 433
allosteric modulation (428) 428
positive allosteric modulators (410) 410
multidisciplinary sciences (396) 396
binding (392) 392
analysis (375) 375
protein-coupled receptors (358) 358
signal transduction (341) 341
gaba (338) 338
rats, sprague-dawley (334) 334
drug design (326) 326
hek293 cells (323) 323
physiological aspects (310) 310
research (308) 308
receptors, metabotropic glutamate - metabolism (303) 303
chemistry, organic (302) 302
brain (290) 290
cell biology (288) 288
agonist (283) 283
protein conformation (283) 283
modulators (280) 280
psychiatry (277) 277
crystal-structure (275) 275
kinetics (275) 275
research article (271) 271
female (270) 270
molecular structure (267) 267
discovery (266) 266
metabotropic glutamate receptors (266) 266
receptor (263) 263
allosteric regulation - physiology (248) 248
cell line (248) 248
identification (247) 247
medicine (247) 247
mutation (247) 247
cho cells (244) 244
in-vivo (235) 235
science (233) 233
protein structure, tertiary (231) 231
rodents (226) 226
nervous system (225) 225
biology (222) 222
rat (217) 217
neurons (211) 211
amino acid sequence (210) 210
cricetinae (207) 207
biochemistry (206) 206
antagonists (203) 203
cricetulus (203) 203
mechanism (198) 198
mental disorders (198) 198
inhibition (197) 197
antagonist (196) 196
pyridines - pharmacology (196) 196
expression (188) 188
negative allosteric modulator (187) 187
receptors, g-protein-coupled - metabolism (186) 186
biophysics (182) 182
gaba receptor (180) 180
agonists (177) 177
calcium - metabolism (176) 176
disease models, animal (175) 175
prefrontal cortex (173) 173
cells, cultured (168) 168
molecular sequence data (168) 168
neuromodulation (168) 168
phosphorylation (168) 168
modulation (167) 167
receptors, metabotropic glutamate - agonists (167) 167
g protein-coupled receptors (166) 166
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5592) 5592
Russian (11) 11
Chinese (10) 10
French (7) 7
Polish (5) 5
Japanese (3) 3
Czech (2) 2
German (2) 2
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
JOURNAL OF NEUROCHEMISTRY, ISSN 0022-3042, 01/2012, Volume 120, pp. 89 - 98
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2013, Volume 110, Issue 26, pp. 10830 - 10835
Journal Article
Neuropharmacology, ISSN 0028-3908, 07/2014, Volume 82, pp. 161 - 173
Previous work has suggested that activation of mGlu5 receptor augments NMDA receptor function and thereby may constitute a rational approach addressing... 
Schizophrenia | Positive allosteric modulator | Neurotoxicity | Metabotropic glutamate receptor | Antipsychotic activity | METABOTROPIC GLUTAMATE-RECEPTOR | PROTEIN-KINASE-C | NEGATIVE SYMPTOMS | FRAGILE-X | NEUROSCIENCES | PREFRONTAL CORTEX | NEURONAL DAMAGE | PHARMACOLOGY & PHARMACY | LONG-TERM POTENTIATION | BINDING-SITES | ACUTE STRESS | METHYL-D-ASPARTATE | Antipsychotic Agents - toxicity | Neurons - pathology | Cricetulus | Rats, Wistar | Benzamides - pharmacokinetics | Allosteric Regulation | Humans | Male | Excitatory Amino Acid Agents - pharmacokinetics | Mice, 129 Strain | Necrosis - pathology | Excitatory Amino Acid Agents - chemistry | Oxadiazoles - toxicity | Receptor, Metabotropic Glutamate 5 - genetics | Necrosis - physiopathology | Neurotoxicity Syndromes - pathology | Neurons - physiology | Female | Cell Death - drug effects | Neurons - drug effects | Oxadiazoles - chemistry | Oxadiazoles - pharmacokinetics | Benzamides - chemistry | CHO Cells | Benzamides - toxicity | Brain - physiopathology | Cells, Cultured | Antipsychotic Agents - pharmacokinetics | Receptor, Metabotropic Glutamate 5 - metabolism | Rats, Sprague-Dawley | Mice, Knockout | Brain - drug effects | Excitatory Amino Acid Agents - toxicity | Animals | Antipsychotic Agents - chemistry | Cell Death - physiology | Neurotoxicity Syndromes - physiopathology | Brain - pathology | Methyl aspartate | Antipsychotic drugs | Glutamate | Index Medicus
Journal Article
Nature Biotechnology, ISSN 1087-0156, 01/2010, Volume 28, Issue 1, pp. 63 - 70
Phosphodiesterase 4 (PDE4), the primary cAMP-hydrolyzing enzyme in cells, is a promising drug target for a wide range of conditions. Here we present seven... 
CAMP-SPECIFIC PHOSPHODIESTERASE | PHOSPHORYLATION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | PROTEIN-KINASE | GENE COMPOSER | SUNCUS-MURINUS | AMP-SPECIFIC PHOSPHODIESTERASE | INHIBITORS | CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE | ROLIPRAM BINDING | ANTIDEPRESSANT DRUGS | Phosphodiesterase Inhibitors - therapeutic use | Phosphodiesterase Inhibitors - adverse effects | Humans | Molecular Sequence Data | Crystallography, X-Ray | Structure-Activity Relationship | Benzhydryl Compounds - chemistry | Benzhydryl Compounds - adverse effects | Phenylurea Compounds - adverse effects | Phenylurea Compounds - chemistry | Drug Design | Phosphodiesterase 4 Inhibitors | Behavior, Animal - drug effects | Biological Assay | Phosphodiesterase Inhibitors - chemistry | Benzhydryl Compounds - therapeutic use | Cyclic Nucleotide Phosphodiesterases, Type 4 - chemistry | Disease Models, Animal | Allosteric Regulation - drug effects | Protein Structure, Tertiary | Amino Acid Sequence | Cell Line | Catalytic Domain | Models, Molecular | Phenylurea Compounds - therapeutic use | Phosphodiesterase Inhibitors - pharmacology | Vomiting - drug therapy | Cognition - drug effects | Animals | Benzhydryl Compounds - pharmacology | Mice | Phenylurea Compounds - pharmacology | Kinetics | Care and treatment | Schizophrenia | Physiological aspects | Genetic aspects | Cellular signal transduction | Cyclic adenylic acid | Research | Phosphodiesterases | Enzymes | Biotechnology | Cellular biology | Molecular biology | Cognitive ability | Crystal structure | Index Medicus
Journal Article